Drawing for G2P

USPTO serial 76131099

G2P

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
OSLICK, SCOTT
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with G2P?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Bevilacqua

MICHAEL J BEVILACQUA HALE & DORR60 STATE ST STE 25BOSTON, MA 02109-1816UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042research and consulting services and data analysis in the fields of genomics, diagnostics, pharmaceuticals clinical trial design and biotechnology; computer services, namely providing access to databases of life sciences information via global, national, and local computer networks; computer services namely creating and customizing databases for others in the field of life sciences; computer services, namely, custom software development; computer services, namely, software support and maintenance; computer services namely contract computational services; consulting services, namely, research, development, validation and testing services for others in the fields of genomics, life sciences and pharmaceuticals medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring an computer tracking of a patient's health progress; research services namely, identification and characterization of peptides and proteins for use in developing diagnostic and therapeutic products and services; research services namely identifying genes; drug screening using cultured microorganisms; chemical and genetic engineering of therapeutic molecules; pharmaceutical research and development services rendered to others; research services for discovering antibodies, antigens drugs, peptides proteins, and gene therapy drugs; providing an online electronic database on global computer networks in the field of genomics diagnostics pharmacogenomics and biotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 12, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 5, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2002EX2GSOU EXTENSION 2 GRANTED—
Nov 6, 2002EXT2SOU EXTENSION 2 FILED—
Nov 6, 2002EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 16, 2002EX1GSOU EXTENSION 1 GRANTED—
Sep 16, 2002PETGPETITION TO REVIVE-GRANTED—
May 22, 2002PETRPETITION TO REVIVE-RECEIVED—
May 22, 2002ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2002EXT1SOU EXTENSION 1 FILED—
Nov 6, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 14, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 25, 2001NPUBNOTICE OF PUBLICATION—
May 4, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2001DOCKASSIGNED TO EXAMINER—
Feb 27, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance